Homeostatic Efficacy of Microporous Polysaccharide Hemosphere in Post-Operative Complications Reduction of Tubeless Percutaneous Nephrolithotomy

Introduction Current hemostatic agents are needed to reduce bleeding and transfusion during several surgery processes. Plant-based absorbable surgical hemostatic agents (microporous polysaccharide hemospheres) are proposed for use in surgical wound sites as an absorbable hemostat and in this study,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Seyed Mohammad Kazem Aghamir, Mahdi Ramezani-binabaj, Fatemeh Khatami, Behrooz Fatahi
Formato: article
Lenguaje:EN
Publicado: Urology Research Center 2020
Materias:
Acceso en línea:https://doaj.org/article/7a15653f45d045fd8192bb1f99397dda
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7a15653f45d045fd8192bb1f99397dda
record_format dspace
spelling oai:doaj.org-article:7a15653f45d045fd8192bb1f99397dda2021-11-29T07:35:05ZHomeostatic Efficacy of Microporous Polysaccharide Hemosphere in Post-Operative Complications Reduction of Tubeless Percutaneous Nephrolithotomy10.22034/TRU.2020.257231.10472717-042Xhttps://doaj.org/article/7a15653f45d045fd8192bb1f99397dda2020-08-01T00:00:00Zhttps://www.transresurology.com/article_119549.htmlhttps://doaj.org/toc/2717-042XIntroduction Current hemostatic agents are needed to reduce bleeding and transfusion during several surgery processes. Plant-based absorbable surgical hemostatic agents (microporous polysaccharide hemospheres) are proposed for use in surgical wound sites as an absorbable hemostat and in this study, we checked its efficacy. Methods This study was run under the Tehran University of Medical Science Ethics Committee observation based on the clinical trial registry criteria (IRCT20190624043991N1). Total numbers of 42 percutaneous nephrolithotomies (PCNL) patients were enrolled, 21 cases hemostatic powder and 21 controls. Hemostatic powder pumped into Amplatz sheath before its extraction. Results The mean age of the case and control groups was 42.1±19.5, and 42.1±18.5 years, respectively. The median stone size was 11.3±1.85cm. Overall, the differences between sex, age, stone size, and location were not statistically significant in the two groups (p-value˃0.05). Serum hemoglobin reduction following PCNL was significant in both groups compared to the serum level before surgery (p-value<0.001). However, the difference was not significant between case and control groups postoperatively (p-value=0.727). Yet, postoperative serum creatinine reduction was not significantly different between the two groups compared to preoperative serum levels (p-value>0.05). Conclusions The present study showed that microporous polysaccharide hemosphere (MPH) did not affect bleeding reduction, hemoglobin decline, and postoperative blood transfusion, and hospital stay.Seyed Mohammad Kazem Aghamir Mahdi Ramezani-binabaj Fatemeh Khatami Behrooz FatahiUrology Research Centerarticlehemostatic agentspercutaneous nephrolitotomytubeless surgeriesmicroporous polysaccharide hemospheresDiseases of the genitourinary system. UrologyRC870-923ENTranslational Research in Urology, Vol 2, Iss 3, Pp 83-88 (2020)
institution DOAJ
collection DOAJ
language EN
topic hemostatic agents
percutaneous nephrolitotomy
tubeless surgeries
microporous polysaccharide hemospheres
Diseases of the genitourinary system. Urology
RC870-923
spellingShingle hemostatic agents
percutaneous nephrolitotomy
tubeless surgeries
microporous polysaccharide hemospheres
Diseases of the genitourinary system. Urology
RC870-923
Seyed Mohammad Kazem Aghamir
Mahdi Ramezani-binabaj
Fatemeh Khatami
Behrooz Fatahi
Homeostatic Efficacy of Microporous Polysaccharide Hemosphere in Post-Operative Complications Reduction of Tubeless Percutaneous Nephrolithotomy
description Introduction Current hemostatic agents are needed to reduce bleeding and transfusion during several surgery processes. Plant-based absorbable surgical hemostatic agents (microporous polysaccharide hemospheres) are proposed for use in surgical wound sites as an absorbable hemostat and in this study, we checked its efficacy. Methods This study was run under the Tehran University of Medical Science Ethics Committee observation based on the clinical trial registry criteria (IRCT20190624043991N1). Total numbers of 42 percutaneous nephrolithotomies (PCNL) patients were enrolled, 21 cases hemostatic powder and 21 controls. Hemostatic powder pumped into Amplatz sheath before its extraction. Results The mean age of the case and control groups was 42.1±19.5, and 42.1±18.5 years, respectively. The median stone size was 11.3±1.85cm. Overall, the differences between sex, age, stone size, and location were not statistically significant in the two groups (p-value˃0.05). Serum hemoglobin reduction following PCNL was significant in both groups compared to the serum level before surgery (p-value<0.001). However, the difference was not significant between case and control groups postoperatively (p-value=0.727). Yet, postoperative serum creatinine reduction was not significantly different between the two groups compared to preoperative serum levels (p-value>0.05). Conclusions The present study showed that microporous polysaccharide hemosphere (MPH) did not affect bleeding reduction, hemoglobin decline, and postoperative blood transfusion, and hospital stay.
format article
author Seyed Mohammad Kazem Aghamir
Mahdi Ramezani-binabaj
Fatemeh Khatami
Behrooz Fatahi
author_facet Seyed Mohammad Kazem Aghamir
Mahdi Ramezani-binabaj
Fatemeh Khatami
Behrooz Fatahi
author_sort Seyed Mohammad Kazem Aghamir
title Homeostatic Efficacy of Microporous Polysaccharide Hemosphere in Post-Operative Complications Reduction of Tubeless Percutaneous Nephrolithotomy
title_short Homeostatic Efficacy of Microporous Polysaccharide Hemosphere in Post-Operative Complications Reduction of Tubeless Percutaneous Nephrolithotomy
title_full Homeostatic Efficacy of Microporous Polysaccharide Hemosphere in Post-Operative Complications Reduction of Tubeless Percutaneous Nephrolithotomy
title_fullStr Homeostatic Efficacy of Microporous Polysaccharide Hemosphere in Post-Operative Complications Reduction of Tubeless Percutaneous Nephrolithotomy
title_full_unstemmed Homeostatic Efficacy of Microporous Polysaccharide Hemosphere in Post-Operative Complications Reduction of Tubeless Percutaneous Nephrolithotomy
title_sort homeostatic efficacy of microporous polysaccharide hemosphere in post-operative complications reduction of tubeless percutaneous nephrolithotomy
publisher Urology Research Center
publishDate 2020
url https://doaj.org/article/7a15653f45d045fd8192bb1f99397dda
work_keys_str_mv AT seyedmohammadkazemaghamir homeostaticefficacyofmicroporouspolysaccharidehemosphereinpostoperativecomplicationsreductionoftubelesspercutaneousnephrolithotomy
AT mahdiramezanibinabaj homeostaticefficacyofmicroporouspolysaccharidehemosphereinpostoperativecomplicationsreductionoftubelesspercutaneousnephrolithotomy
AT fatemehkhatami homeostaticefficacyofmicroporouspolysaccharidehemosphereinpostoperativecomplicationsreductionoftubelesspercutaneousnephrolithotomy
AT behroozfatahi homeostaticefficacyofmicroporouspolysaccharidehemosphereinpostoperativecomplicationsreductionoftubelesspercutaneousnephrolithotomy
_version_ 1718407534899888128